Analysen zu BioNTech (ADRs)
| 22.08.25 | BioNTech Neutral | UBS AG | |
| 05.08.25 | BioNTech Buy | Deutsche Bank AG | |
| 05.08.25 | BioNTech Neutral | UBS AG | |
| 05.08.25 | BioNTech Buy | Jefferies & Company Inc. | |
| 13.06.25 | BioNTech Buy | Deutsche Bank AG | |
| 03.06.25 | BioNTech Buy | Jefferies & Company Inc. | |
| 03.06.25 | BioNTech Buy | Deutsche Bank AG | |
| 03.06.25 | BioNTech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.06.25 | BioNTech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.05.25 | BioNTech Buy | Jefferies & Company Inc. | |
| 13.05.25 | BioNTech Buy | Deutsche Bank AG | |
| 07.05.25 | BioNTech Neutral | UBS AG | |
| 06.05.25 | BioNTech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.05.25 | BioNTech Buy | Jefferies & Company Inc. | |
| 29.04.25 | BioNTech Buy | Deutsche Bank AG | |
| 28.04.25 | BioNTech Buy | Jefferies & Company Inc. | |
| 25.04.25 | BioNTech Buy | Deutsche Bank AG | |
| 26.03.25 | BioNTech Buy | Deutsche Bank AG | |
| 21.03.25 | BioNTech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.03.25 | BioNTech Buy | Goldman Sachs Group Inc. | |
| 14.03.25 | BioNTech Buy | Deutsche Bank AG | |
| 11.03.25 | BioNTech Buy | Goldman Sachs Group Inc. | |
| 11.03.25 | BioNTech Neutral | UBS AG | |
| 11.03.25 | BioNTech Buy | Deutsche Bank AG | |
| 10.03.25 | BioNTech Neutral | JP Morgan Chase & Co. | |
| 06.03.25 | BioNTech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.01.25 | BioNTech Neutral | JP Morgan Chase & Co. | |
| 15.01.25 | BioNTech Buy | Goldman Sachs Group Inc. | |
| 17.12.24 | BioNTech Neutral | JP Morgan Chase & Co. | |
| 12.12.24 | BioNTech Buy | Jefferies & Company Inc. | |
| 11.12.24 | BioNTech Neutral | JP Morgan Chase & Co. | |
| 27.11.24 | BioNTech Buy | Deutsche Bank AG | |
| 26.11.24 | BioNTech Buy | Goldman Sachs Group Inc. | |
| 26.11.24 | BioNTech Buy | Jefferies & Company Inc. | |
| 19.11.24 | BioNTech Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.11.24 | BioNTech Buy | Goldman Sachs Group Inc. | |
| 15.11.24 | BioNTech Neutral | JP Morgan Chase & Co. | |
| 14.11.24 | BioNTech Buy | Goldman Sachs Group Inc. | |
| 12.11.24 | BioNTech Buy | Deutsche Bank AG | |
| 08.11.24 | BioNTech Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | BioNTech Neutral | JP Morgan Chase & Co. | |
| 05.11.24 | BioNTech Buy | Deutsche Bank AG | |
| 04.11.24 | BioNTech Buy | Jefferies & Company Inc. | |
| 03.10.24 | BioNTech Buy | Deutsche Bank AG | |
| 02.10.24 | BioNTech Neutral | UBS AG | |
| 19.09.24 | BioNTech Buy | Deutsche Bank AG | |
| 18.09.24 | BioNTech Neutral | UBS AG | |
| 17.09.24 | BioNTech Buy | Jefferies & Company Inc. | |
| 16.09.24 | BioNTech Neutral | JP Morgan Chase & Co. | |
| 13.09.24 | BioNTech Hold | Jefferies & Company Inc. |
Aktuelle Aktienanalysen
| 05.09.25 | CTS Eventim Buy | Jefferies & Company Inc. | |
| 05.09.25 | Delivery Hero Buy | Jefferies & Company Inc. | |
| 05.09.25 | Inditex Buy | Jefferies & Company Inc. | |
| 05.09.25 | Tesla Sell | UBS AG | |
| 05.09.25 | Orsted Neutral | JP Morgan Chase & Co. | |
| 05.09.25 | BBVA Buy | Jefferies & Company Inc. | |
| 05.09.25 | Airbus Outperform | RBC Capital Markets | |
| 05.09.25 | Broadcom Buy | UBS AG | |
| 05.09.25 | Novartis Neutral | UBS AG | |
| 05.09.25 | Novo Nordisk Neutral | UBS AG | |
| 05.09.25 | Sanofi Neutral | Goldman Sachs Group Inc. | |
| 05.09.25 | freenet Buy | Warburg Research | |
| 05.09.25 | Bechtle Buy | Deutsche Bank AG | |
| 05.09.25 | Infineon Buy | Deutsche Bank AG | |
| 05.09.25 | Sanofi Buy | Deutsche Bank AG | |
| 05.09.25 | AIXTRON Hold | Deutsche Bank AG | |
| 05.09.25 | Airbus Buy | Jefferies & Company Inc. | |
| 05.09.25 | Orsted Sector Perform | RBC Capital Markets | |
| 05.09.25 | Orsted Hold | Jefferies & Company Inc. | |
| 05.09.25 | Walmart Buy | UBS AG | |
| 05.09.25 | UBM Development buy | Erste Group Bank | |
| 05.09.25 | ATOSS Software Buy | Deutsche Bank AG | |
| 05.09.25 | BAT Buy | UBS AG | |
| 05.09.25 | Hermès Neutral | UBS AG | |
| 05.09.25 | L'Oréal Neutral | UBS AG | |
| 05.09.25 | Sanofi Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.09.25 | Sixt Buy | UBS AG | |
| 05.09.25 | RWE Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.09.25 | Schaeffler Neutral | UBS AG | |
| 05.09.25 | ASML NV Buy | UBS AG | |
| 05.09.25 | QIAGEN Buy | Jefferies & Company Inc. | |
| 05.09.25 | Infineon Neutral | JP Morgan Chase & Co. | |
| 04.09.25 | Sanofi Buy | Jefferies & Company Inc. | |
| 04.09.25 | Saint-Gobain Overweight | JP Morgan Chase & Co. | |
| 04.09.25 | Iberdrola Sector Perform | RBC Capital Markets | |
| 04.09.25 | Sanofi Outperform | Bernstein Research | |
| 04.09.25 | L'Oréal Hold | Jefferies & Company Inc. | |
| 04.09.25 | HelloFresh Neutral | JP Morgan Chase & Co. | |
| 04.09.25 | RWE Outperform | RBC Capital Markets | |
| 04.09.25 | thyssenkrupp nucera Outperform | RBC Capital Markets | |
| 04.09.25 | Deutsche Telekom Overweight | JP Morgan Chase & Co. | |
| 04.09.25 | LVMH Moet Hennessy Louis Vuitton Hold | Jefferies & Company Inc. | |
| 04.09.25 | Allianz Underweight | Barclays Capital | |
| 04.09.25 | AXA Overweight | Barclays Capital | |
| 04.09.25 | Assicurazioni Generali Underweight | Barclays Capital | |
| 04.09.25 | Hannover Rück Underweight | Barclays Capital | |
| 04.09.25 | Münchener Rückversicherungs-Gesellschaft Overweight | Barclays Capital | |
| 04.09.25 | Swiss Re Underweight | Barclays Capital | |
| 04.09.25 | Zurich Insurance Equal Weight | Barclays Capital | |
| 04.09.25 | ASML NV Equal Weight | Barclays Capital |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.